• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Flight-Associated Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 Corroborated by Whole-Genome Sequencing

Mary Wilson

Well-known member
Volume 26, Number 12—December 2020

Hollie Speake, Anastasia Phillips, Tracie Chong, Chisha Sikazwe, Avram Levy, Jurissa Lang, Benjamin Scalley, David J. Speers, David W. Smith, Paul Effler, and Suzanne P. McEvoy

Abstract

To investigate potential transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) during a domestic flight within Australia, we performed epidemiologic analyses with whole-genome sequencing. Eleven passengers with PCR-confirmed SARS-CoV-2 infection and symptom onset within 48 hours of the flight were considered infectious during travel; 9 had recently disembarked from a cruise ship with a retrospectively identified SARS-CoV-2 outbreak. The virus strain of those on the cruise and the flight was linked (A2-RP) and had not been previously identified in Australia. For 11 passengers, none of whom had traveled on the cruise ship, PCR-confirmed SARS-CoV-2 illness developed between 48 hours and 14 days after the flight. Eight cases were considered flight associated with the distinct SARS-CoV-2 A2-RP strain; the remaining 3 cases (1 with A2-RP) were possibly flight associated. All 11 passengers had been in the same cabin with symptomatic persons who had primary, culture-positive, A2-RP cases. This investigation provides evidence of flight-associated SARS-CoV-2 transmission.

Dr Speake is a dual trainee in General Practice and Public Health Medicine and is affiliated with the University of Notre Dame in Fremantle. She worked as a Public Health Registrar in the public health response to the SARS-CoV-2 outbreak in Perth.

Acknowledgment
We thank the Molecular Diagnostics staff of PathWest QE2 Medical Centre and Fiona Stanley Hospital for accessing specimens for sequencing, and we thank the public health nurses in the North Metropolitan Health Service who undertook the initial contact tracing.

Dr Speake is a dual trainee in General Practice and Public Health Medicine and is affiliated with the University of Notre Dame in Fremantle. She worked as a Public Health Registrar in the public health response to the SARS-CoV-2 outbreak in Perth.

https://wwwnc.cdc.gov/eid/article/26/12/20-3910_article
 
Back
Top Bottom